Natco Pharma Announcements
Natco Pharma Limited has informed the Exchange regarding a press release dated October 10, 2025, titled "Updates on proposed acquisition of shares in Adcock Ingram...
10 Oct, 2025 | 01:21pm • Source: NSE
Update on proposed acquisition of Adcock Ingram Holdings Limited
10 Oct, 2025 | 01:09pm • Source: BSE
Compliances - Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2025
09 Oct, 2025 | 06:35pm • Source: BSE
Legal Update regarding RISDIPLAM - commercial Appellate Division of the Hon''ble Delhi High Court Dismissed Appeal
09 Oct, 2025 | 05:36pm • Source: BSE
Mr. G Vijay Kiran Kumar appointed as Vice President - Corporate Quality Assurance (formulations) with effect from 9th October, 2025
09 Oct, 2025 | 04:45pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Nannapaneni
03 Oct, 2025 | 09:56am • Source: BSE
We would like to inform that De. Santhan Gopalakrishnan Vaidyanathan, Senior Vice President - ARD is superannuating from the Company w.e.f. the closure of business...
30 Sep, 2025 | 05:32pm • Source: BSE
Scrutinizer''s Report for the AGM held on 25th September, 2025
25 Sep, 2025 | 06:21pm • Source: BSE
Proceedings of the 42nd Annual General Meeting of the Company
25 Sep, 2025 | 12:17pm • Source: BSE
Outcome of Board Meeting
25 Sep, 2025 | 10:47am • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satya Vani Nannapaneni
19 Sep, 2025 | 10:53am • Source: BSE
Natco''s Pharma Division located in Kothur, Hyderabad, India has now received Establishment Inspection Report (EIR) classifying the facility as Voluntary Action Indicated (VAI) from the...
18 Sep, 2025 | 09:49am • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satya Vani Nannapaneni
15 Sep, 2025 | 05:50pm • Source: BSE
Natco Pharma Limited has informed the Exchange regarding a press release dated September 10, 2025, titled "Update
10 Sep, 2025 | 12:12pm • Source:
Press Release
10 Sep, 2025 | 11:23am • Source: BSE
Intimation of Investor Meet
04 Sep, 2025 | 12:56pm • Source: BSE
News Paper Publication
01 Sep, 2025 | 04:48pm • Source: BSE
Business Responsibility and Sustainability Report for FY 2024-25
29 Aug, 2025 | 06:32pm • Source: BSE
Notice of 42nd Annual General Meeting
29 Aug, 2025 | 06:30pm • Source: BSE